Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus...

Area of Science:

• Immunology
• Rheumatology
• Clinical Chemistry

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune complex deposition.
• Monitoring disease activity and treatment response in SLE is crucial for patient management.

Purpose of the Study:

• To investigate the relationship between DNA-binding activity, complement consumption, and circulating immune complexes in SLE patients.
• To assess the utility of serial measurements of these biomarkers in managing SLE.

Main Methods:

• Analysis of 89 sera from 19 SLE patients.
• Measurement of DNA-binding activity.
• Assay of complement components (C3, C4, CH50) and activation products (C3i).
• Detection of circulating immune complexes using various methods.

Main Results:

• A strong correlation was observed between high DNA-binding activity, rising C3i, and decreasing C3, C4, and CH50 levels.
• Serial complement measurements provided valuable supplemental information.
• Circulating immune complexes were detected in nearly half of sera with DNA binding >70%.

Conclusions:

• Serial monitoring of DNA-binding activity, complement levels, and immune complexes is valuable for SLE patient management.
• These biomarkers collectively offer a comprehensive view of disease activity.
• Integrated assessment aids in optimizing therapeutic strategies for SLE.